On July 2nd, Sanofi's first China Innovation and Operations Center (hereinafter referred to as the "Center") officially opened its office space in Chengdu. The center was officially established in March 2026, and the completion of the new site marks a new stage in the center's construction. As another key investment for Sanofi in Southwest China, the opening of the new office not only further demonstrates Sanofi's solid commitment to deepening its presence in the Chinese market, but also highlights China's increasingly important position as a global hub for innovation, talent development, and business operations. It demonstrates the company's full confidence in China's innovation ecosystem, high-quality talent team, and long-term growth potential.

The China Innovation and Operations Center is positioned as Sanofi's intensive business engine and a core part of the company's global business modernization transformation. It integrates multiple key strategic functions, including research and development support, digitization, manufacturing and supply chain services, medical affairs, human resources and talent services, procurement services, and business empowerment. The center is an important component of Sanofi's global business operations network, which aims to gather multiple cross functional strategic capabilities to support scale innovation, operational excellence, and business transformation. The center will leverage advanced data analysis capabilities and artificial intelligence solutions to continuously improve operational efficiency, accelerate decision-making processes, and empower Sanofi's end-to-end value creation.

Madeleine Roach, Global Executive Vice President and Head of Business Operations at Sanofi, said, "The China Innovation and Operations Center is a crucial step in Sanofi's business operations transformation. As an important member of the global business operations network, the center not only integrates global excellence with local flexibility advantages, but also gathers professional capabilities from multiple strategic functional areas. It is a microcosm of Sanofi's' China speed ', representing our ability to act quickly, think innovatively, and execute excellently. We will rely on the construction of the center to create a more collaborative, agile, and future oriented organization, and create more profound value for Chinese patients

Madeleine Roach, Global Executive Vice President and Head of Business Operations at Sanofi, delivered a speech at the opening ceremony of the China Innovation and Operations Center and the new office in Chengdu

Our commitment to the Chinese market is deeply rooted in continuous and tangible investment in every key capability, "said Shi Wang, President of Sanofi Greater China." The China Innovation and Operations Center marks a further improvement of our end-to-end value chain in China. By deeply synergizing research and development, manufacturing, commercialization, and today's strong business operations capabilities, we are unleashing unprecedented agility. This strategic layout is Sanofi's vote of confidence in the vitality of the Chinese market, which will ensure that we continue to make long-term contributions and bring transformative innovation to patients, partners, and the entire healthcare ecosystem

The newly opened office is located in Chengdu High tech Industrial Development Zone, with an area of over 12600 square meters. The new location adheres to the design concept of people-oriented, equipped with advanced hardware facilities and flexible collaboration spaces, committed to enhancing employee experience, stimulating team creativity, and improving work efficiency. This is not only an office space, but also a vivid embodiment of Sanofi's commitment to innovation and excellence culture, laying a solid foundation for the company to accelerate capacity building and support future business development.

Sanofi China Innovation and Operations Center Chengdu New Office

With the continuous promotion of the center construction, it will also become a cradle for cultivating local young talents and future leadership. It is expected that by the end of 2026, the China Innovation and Operations Center will create approximately 600 high-value professional positions for the local area, covering multiple strategic functional areas. By introducing China's innovative vitality, outstanding talents, and digital advantages into Sanofi's global operational system, the center will not only support the company's own transformation, but also continue to assist the Chinese life science industry in building a more innovative, resilient, and synergistic ecosystem.